SPONSOR
Akebia Therapeutics
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Focal Segmental Glomerulosclerosis
Akebia Therapeutics is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Focal Segmental Glomerulosclerosis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Akebia Therapeutics
How many clinical trials has Akebia Therapeutics sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Akebia Therapeutics, of which 1 are actively recruiting participants. These trials cover conditions including Focal Segmental Glomerulosclerosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Akebia Therapeutics research focus on?
Akebia Therapeutics clinical trials span Focal Segmental Glomerulosclerosis. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Akebia Therapeutics clinical trial?
To participate in a Akebia Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Akebia Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Akebia Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology